Label: CLEAR SMART BLEMISH SPOT TREATMENT- salicyclic acid gel
- NDC Code(s): 68828-245-01
- Packager: Jafra Cosmetics International Inc
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 28, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
- Purpose
- Uses
- Warnings
- KEEP OUT OF REACH OF CHILDREN
-
Directions
- Clean the skin thoroughly before applying
- Cover the entire affected area with a thin layer 1 to 3 times daily
- Avoid contact with eyes.
- Because excessive drying may of the skin may occur, start with 1 application daily, then gradually increase to 2 or 3 times daily if needed or as directed by a doctor
- If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
-
INACTIVE INGREDIENT
Inactive ingredients
Allantoin, Bisabolol, Butylene Glycol, Butyrospermum Parkii (Shea) Butter, Carbomer, Decylene Glycol, Dipropylene Glycol, Disodium EDTA, Ethylhexylglycerin, Glycerin, Honey Extract, Hydrogenated Lecithin, Lecithin, Maltodextrin, Niacinamide, Phenethyl Alcohol, Phenoxyethanol, Spiraea Ulmaria Extract, Polyacrylate-13/Polyisobutene/ Polysorbate 20, Royal Jelly Powder, Royal Jelly, SD Alcohol 40-B, Sodium Hydroxide, Succinic Acid, Tetrapeptide-45, Water/Aqua, Zymomonas Ferment Extract.
- Package label
-
INGREDIENTS AND APPEARANCE
CLEAR SMART BLEMISH SPOT TREATMENT
salicyclic acid gelProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:68828-245 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID 1 g in 100 mL Inactive Ingredients Ingredient Name Strength SODIUM HYDROXIDE (UNII: 55X04QC32I) WATER (UNII: 059QF0KO0R) SHEA BUTTER (UNII: K49155WL9Y) ETHYLHEXYLGLYCERIN (UNII: 147D247K3P) GLYCERIN (UNII: PDC6A3C0OX) ALLANTOIN (UNII: 344S277G0Z) NIACINAMIDE (UNII: 25X51I8RD4) LEVOMENOL (UNII: 24WE03BX2T) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) HONEY (UNII: Y9H1V576FH) HYDROGENATED SOYBEAN LECITHIN (UNII: H1109Z9J4N) MALTODEXTRIN (UNII: 7CVR7L4A2D) LECITHIN, SOYBEAN (UNII: 1DI56QDM62) PHENYLETHYL ALCOHOL (UNII: ML9LGA7468) CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC) DECYLENE GLYCOL (UNII: S57M60MI88) DIPROPYLENE GLYCOL (UNII: E107L85C40) EDETATE DISODIUM (UNII: 7FLD91C86K) PHENOXYETHANOL (UNII: HIE492ZZ3T) ROYAL JELLY (UNII: L497I37F0C) ALCOHOL (UNII: 3K9958V90M) SUCCINIC ACID (UNII: AB6MNQ6J6L) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:68828-245-01 15 mL in 1 TUBE; Type 0: Not a Combination Product 05/11/2020 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M006 05/11/2020 Labeler - Jafra Cosmetics International Inc (041676479) Establishment Name Address ID/FEI Business Operations Distribuidora Comercial Jafra, S.A. de C.V. 951612777 manufacture(68828-245)